Active ingredient of psoralen and preparation method thereof

A kind of technology of psoralen and psoralen B, applied in the field of medicine

Inactive Publication Date: 2010-09-08
北京卓越同舟药物研究院有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But so far there is no new drug prepared from the active ingredients extracted fr

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Active ingredient of psoralen and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] A psoralen, the psoralen content is 90.01%, and contains two impurities, the content of the impurity psoralen B is 7.92%, and the content of the impurity bakuchiol is 0.99%.

Embodiment 2

[0067] A psoralen, the psoralen content is 96.92%, and contains two impurities, the content of the impurity psoralen B is 2.80%, and the content of the impurity bakuchiol is 0.24%.

Embodiment 3

[0069] A psoralen, the psoralen content is 94.37%, and contains two impurities, the impurity psoralen B content is 4.29%, and the impurity bakuchiol content is 0.51%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an active ingredient of a natural medicament and a preparation method thereof. The active ingredient is characterized in that: the psoralen content is 90 to 97 percent; the active ingredient contains two impurities; and the impurity corylifolinin content is 3 to 8 percent, and the impurity bakuchiol content is less than 1 percent. Preferably, the psoralen content is 95 to 97 percent; the impurity corylifolinin content is 3 to 4.5 percent, and the impurity bakuchiol content is less than 0.5 percent. More preferably, the psoralen content is 96 to 97 percent; the impurity corylifolinin content is 3 to 4 percent, and the impurity bakuchiol content is less than 0.1 percent. Pharmacological experiments prove that the active ingredient has excellent effect of treating male erectile dysfunction.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to an active ingredient of psoralen traditional Chinese medicine. Background technique [0002] The "Measures for the Administration of Drug Registration" implemented on October 1, 2007 gave greater encouragement to the research and development of innovative drugs, and the number of domestic innovative drug applications also showed a clear upward trend. However, compared with the research on new drug impurities in developed countries, there is still a certain gap in the research level of our country. The main gap in impurity research is reflected in the systematicness and standardization of impurity research. This directly limits the level of drug research and the improvement of drug quality in our country. It is an urgent problem for many medical workers to clarify the research purpose, research ideas and related technologies for impurities. [0003] The traditional Chinese med...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D493/04A61K31/37A61P15/10A61P15/00
Inventor 王爱民安晓雪周亚君
Owner 北京卓越同舟药物研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products